Prot# 01-04-TL-242-011: A Pivotal, Multicenter, Multinational, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tak-242 in Adults with Severe Sepsis

Project: Research project

Project Details

StatusFinished
Effective start/end date12/15/057/19/11

Funding

  • PPD Development (01-04-TL-242-011)
  • Takeda Development Center Americas, Inc. (01-04-TL-242-011)